Zobrazeno 1 - 10
of 10
pro vyhledávání: '"D I Papac"'
Publikováno v:
The Journal of Immunology. 157:198-206
Matrix-assisted laser desorption mass spectrometry in combination with proteolytic protection assays has been used to identify the functional epitope on HIV-1 IIIB p26 recognized by a mAb. In this procedure, the intact protein is affinity bound to an
Autor:
D I, Papac, Z, Shahrokh
Publikováno v:
Pharmaceutical research. 18(2)
This review highlights the many roles mass spectrometry plays in the discovery and development of new therapeutics by both the pharmaceutical and the biotechnology industries. Innovations in mass spectrometer source design, improvements to mass accur
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 157(1)
Matrix-assisted laser desorption mass spectrometry in combination with proteolytic protection assays has been used to identify the functional epitope on HIV-1 IIIB p26 recognized by a mAb. In this procedure, the intact protein is affinity bound to an
Autor:
Jeffrey Lockman, R. Gordillo, Robert O. Carlson, Vijay Baichwal, Chad Bradford, G. G. Mather, B. R. Murphy, J.A. Willardsen, T. C. Fleischer, D. I. Papac
Publikováno v:
Journal of Clinical Oncology. 29:10529-10529
10529 Background: MPC‐9528 is a potent, selective, orally bioavailable inhibitor of nicotinamide phosphoribosyltransferase (Nampt) that catalyzes the rate-limiting step in NAD biosynthesis from nic...
Publikováno v:
Journal of Clinical Oncology. 29:e13016-e13016
e13016 Background: MPC-3100, an orally bioavailable synthetic inhibitor of HSP90, has demonstrated efficacy in animal models and is currently in a phase I clinical study in cancer patients. Toxicol...
Publikováno v:
Journal of Clinical Oncology. 29:e13019-e13019
e13019 Background: MPC-3100 is an oral synthetic inhibitor of HSP90, in a phase I safety study in cancer patients. Major cytochrome P450 (CYP450) and UDP-glucuronosyltransferase (UGT) isozymes were...
Autor:
Robert O. Carlson, D. I. Papac, K. H. Zavitz, Vijay Baichwal, G. G. Mather, Leslie Reeves, Andrew P. Beelen, Chad Bradford, J. T. Jones
Publikováno v:
Journal of Clinical Oncology. 29:e13080-e13080
e13080 Background: MPC-6827 is a small molecule microtubule disrupting agent that is being evaluated in phase II studies for the treatment of glioblastoma multiforme. It crosses the blood-brain bar...
Autor:
Jeffrey Lockman, J. Jay Boniface, Ryan T. Terry-Lorenzo, J.A. Willardsen, R.O. Carlson, V.R. Baichwal, J.P. Green, W.R. Judd, L. DeMie, D. I. Papac
Publikováno v:
European Journal of Cancer Supplements. 8:4
Publikováno v:
The Journal of biological chemistry. 267(24)
Bovine rhodopsin has been reported to be S-palmitylated at cysteines 322 and 323 (Ovchinnikov, Y. A., Abdulaev, N. G., and Bogachuk, A.S. (1988) FEBS Lett. 230, 1-5). Using a combination of enzymatic and chemical cleavage techniques in conjunction wi
Autor:
D I, Papac, M R, Franklin
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 16(2)
The effects of N-benzylimidazole on hepatic microsomal and cytosolic drug-metabolizing enzymes were compared to the effects produced by phenobarbital, beta-naphthoflavone, a polycyclic aromatic hydrocarbon, and Aroclor 1254, a polychlorinated bipheny